India is considering a significant public health measure—barring the use of cough and cold syrups for young children. This move comes amid growing safety concerns raised by pediatric experts and regulatory authorities. Infants are particularly vulnerable to the side effects of these medications, and research suggests that the risks often outweigh the benefits. The proposed restriction aims to safeguard young children and promote safer alternatives for managing cough and cold